A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches
- First Posted Date
- 2005-11-22
- Last Posted Date
- 2014-02-21
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 447
- Registration Number
- NCT00257010
Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
Phase 4
Completed
- Conditions
- MigraineClassic MigraineCommon Migraine
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 406
- Registration Number
- NCT00210496
A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache
Phase 4
Completed
- Conditions
- Migraine
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 378
- Registration Number
- NCT00210509
A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents
Phase 3
Completed
- Conditions
- Migraine
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen-Ortho LLC
- Target Recruit Count
- 866
- Registration Number
- NCT00210483
© Copyright 2025. All Rights Reserved by MedPath